Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00812877
Other study ID # NIDCR-16752
Secondary ID U01DE016750
Status Completed
Phase N/A
First received December 18, 2008
Last updated May 3, 2015
Start date May 2009
Est. completion date May 2012

Study information

Verified date May 2015
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents


Description:

The purpose of this study was to test two dental products used as direct pulp capping agent for the permanent teeth. The two products were mineral trioxide aggregate and calcium hydroxide.

A direct pulp capping consists of covering an exposed tooth pulp (the inside portion of the tooth where the blood vessels and nerve supply the tooth) with a medication to maintain tooth vitality. Different events can cause the pulp to be exposed, for example a deep cavity, or an accident where the outer portion of the tooth fractures. When this occurs, it is sometimes possible to place a medicine over the top of the exposure (a "cap") in an effort to allow the pulp to heal on its own. Our study intended to compare two of those medicines, calcium hydroxide and mineral trioxide aggregate, both Federal Drug Administration (FDA) approved products, to determine if one performed better than the other.

The study was conducted with patients recruited by Northwest PRECEDENT practitioners. The practitioners interested in participating in the study were randomized (assigned by chance) to one of the two intervention groups: a treatment group (mineral trioxide aggregate) and a control group (calcium hydroxide).

Direct pulp capping was completed on permanent (adult) teeth with pulps exposed due to decay, trauma (injury) or mechanical exposure. Treated teeth were followed over two years to determine how well they responded to the treatment.

All patients who had a pulp exposure of a permanent tooth were eligible for the study. These patients were further asked to participate in the study if they satisfied the inclusion criteria for the study and did not present any of the exclusion criteria stated in the study protocol.

A tooth that received a pulp cap was treated in the following manner: After a tooth pulp had been exposed and the tooth was found to be suitable for a pulp cap, the exposure and surrounding area was cleaned by gentle rinsing with water. A cotton pellet moistened with 5.25% sodium hypochlorite was placed over the exposure and allowed to sit for 1-2 minutes. This procedure was used to control pulp bleeding and remove the germs from that area. After the initial period, the cotton pellet was removed and the area inspected. If bleeding continued, a new cotton pellet moistened in the sodium hypochlorite solution was reapplied to the area for an additional several minutes. This was repeated until bleeding was controlled or the practitioner decided that pulp capping was not appropriate for the situation. Once the bleeding was controlled from the exposure, one of the two pulp capping agents was applied to the pulp exposure site.

Practices were assigned by chance into one of two treatment groups, those that completed direct pulp capping with mineral trioxide aggregate and those that completed direct pulp capping with calcium hydroxide, both FDA approved agents for this purpose. The handling characteristics of the two materials were so different, that it was not practical to blind the practitioners as to which material they were using. Likewise, training in the use of each material was required. It was believed that it was more important that the practitioner become familiar and competent in the use of one of the materials to ensure it was used appropriately, than it was to have practitioners use both materials and confuse procedures between them. Since time was a critical element in the success or failure of direct pulp capping, the patients were consented to participate in the study after the procedure was done. A resin-modified glass ionomer liner (e.g. Vitrebond, Fuji Lining Cement, Fuji II LC, Vitremer) was placed over the pulp capping agent. This liner sealed the pulp capping agent and protected the pulp from being infiltrated with bacteria. After the resin-modified glass ionomer lining material was set, the final filling was placed.

Two types of instruments were used in this study:

Study participant data collection form This form collected two types of data: demographic and clinical data. The demographic part gathered information regarding patient age, gender, and race. The clinical form collected data regarding the clinical and x-ray evaluation of the tooth treated with a direct pulp cap: condition of the tooth, the type of pulp exposure (by decay, by injury or during tooth preparation), patients' complaints regarding the tooth, and results of diagnostic tests (x-ray, pain to biting or temperature, etc) were recorded.

Practitioner feedback survey A survey was administered to all practitioners who participated in the study. This survey included a series of questions designed to evaluate the communication between the member practitioners and the network, practitioner/staff training, patient recruitment, obtaining informed consent, data collection and data transmission, including the electronic data capture system. The survey also tried to determine how well the offices were able to combine the research in a regular daily office schedule in order to determine if a research project would affect the normal day-to-day routine.

The intent of this study was to find out which of the two products yielded better results as a pulp capping agent. In order to detect this, the failure rates in the two treatment groups were compared using statistical tests. Distributions of covariates in the two treatment groups were compared and clinical judgment was used to identify covariates with serious group imbalances that would cause an unusual result for the primary analysis. Logistic regression was used to compare failure rates while adjusting for any covariates that were imbalanced between groups.


Recruitment information / eligibility

Status Completed
Enrollment 376
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 7 Years and older
Eligibility Inclusion Criteria:

1. Any patient 7 years old or older who requires a direct pulp cap of a permanent tooth.

2. The tooth must exhibit a vital pulp upon exposure.

3. The exposure can be due to mechanical, traumatic or carious causes.

4. Patient will be available for the two year follow-up period.

Exclusion Criteria:

1. Any primary tooth requiring a direct pulp cap.

2. Tooth demonstrates any radicular radiolucency on a radiograph.

3. Tooth exhibits spontaneous pain.

4. Tooth exhibits lingering (more than 5 seconds) pain to temperature or biting stimulus.

5. Non-English and/or non-Spanish speaking subjects.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Mineral Trioxide Aggregate
Pulp capping agent, Mineral TrioxideAggregate
Calcium Hydroxide
Pulp capping agent, Calcium Hydroxide

Locations

Country Name City State
United States Oregon Health & Science University Portland Oregon

Sponsors (3)

Lead Sponsor Collaborator
Oregon Health and Science University National Institute of Dental and Craniofacial Research (NIDCR), University of Washington

Country where clinical trial is conducted

United States, 

References & Publications (2)

Hilton TJ, Ferracane JL, Mancl L; Northwest Practice-based Research Collaborative in Evidence-based Dentistry (NWP). Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial. J Dent Res. 2013 Jul;92(7 Suppl):16S-22S. doi: 10.1 — View Citation

Hilton TJ. Keys to clinical success with pulp capping: a review of the literature. Oper Dent. 2009 Sep-Oct;34(5):615-25. doi: 10.2341/09-132-0. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Tooth Survival No recommendation for tooth extraction or root canal therapy. Only one tooth was enrolled/assessed per participant. Up to two years No
Secondary Pulp Vitality No evidence of pulpal resorption or calcification or periradicular radiolucency Up to two years No
See also
  Status Clinical Trial Phase
Completed NCT02019563 - MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial Phase 2
Not yet recruiting NCT04330768 - Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial N/A
Completed NCT02789423 - Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth N/A
Completed NCT01468480 - Human Pulpal Response After Pulp Capping With Four Different Agents Phase 2/Phase 3
Completed NCT02487329 - The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping N/A
Completed NCT00187850 - The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy N/A
Completed NCT03631511 - Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA N/A
Completed NCT02492841 - Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth Phase 2/Phase 3